PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License
14. November 2024 09:20 ET
|
PharmAla Biotech
PharmAla reaches agreement in principle to trade with a clinical trial to trade its LaNeo MDMA for a data license to the trial outcomes.
Aviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress Disorder
13. November 2024 08:52 ET
|
Aviv Clinics
ORLANDO, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain health clinics in the world, shares the results of a groundbreaking study revealing a specialized...
PharmAla to supply LaNeo MDMA for Clinical Trial at Yale
07. November 2024 09:20 ET
|
PharmAla Biotech
PharmAla to supply Yale University with MDMA for clinical trial
$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment
10. Oktober 2024 10:00 ET
|
Unyte Health
The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.
PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA
08. Oktober 2024 08:55 ET
|
PharmAla Biotech
PharmAla signs contract to develop novel dosage form of LaNeo MDMA, to be used in clinical trial at University of Texas San Antonio
American Addiction Centers Names Navy Veteran as New VP of Military and Veteran Affairs
03. Oktober 2024 13:47 ET
|
American Addiction Centers, Inc.
BRENTWOOD, Tenn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- In an effort to increase access to care for Veterans, American Addiction Centers (AAC) has appointed Sazha Alexandra Ramos as its new Vice...
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
11. September 2024 08:00 ET
|
Halberd Corp.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
MAPS Awards Grant for Pilot MDMA-assisted Massed Exposure Therapy Trial
27. August 2024 07:00 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS, which has incubated and funded cutting-edge psychedelic research for decades, is continuing to advance our understanding of psychedelic-assisted therapiesThis study is one of the first trials...
Third Annual Hiking Event Brings Awareness to Chronic Pain in Canadian Veterans
26. August 2024 10:57 ET
|
Chronic Pain Centre of Excellence for Canadian Veterans
HAMILTON, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Nine Canadian military Veterans living with chronic pain from across Canada completed the third annual Military Veterans Alpine Challenge (Alpine...
MedX Holdings, Inc. (MEDH) Resumes Trading on the OTC Markets, Emerges from Expert Market Dormancy
22. August 2024 09:00 ET
|
MedX Holdings, Inc.
MedX Holdings, Inc. (OTC: MEDH), an upcoming dynamic player in the cannabis sector, is thrilled to announce that the company is now trading on OTC Markets